Global wilson's disease (WD) drugs market 2024-2028

PUBLISHED: July 9, 2024

PAGES: 159 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The wilson's disease (wd) drugs market is forecasted to grow by USD 173.3 mn during 2023-2028, accelerating at a CAGR of 5.84% during the forecast period. The report on the wilson's disease (wd) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness among people for disease treatment, increase in prevalence of wilson's disease, and rise in adoption of early diagnosis.

Technavio's wilson's disease (wd) drugs market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.41%
CAGR	5.84%
Incremental Value	$173.3mn

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online pharmacies

By Product

Chelators
Minerals

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing prevalence of chronic pain as one of the prime reasons driving the wilson's disease (wd) drugs market growth during the next few years. Also, increasing introduction of patient assistance programs and advancement in research and development activities for drug development will lead to sizable demand in the market.

The report on the wilson's disease (wd) drugs market covers the following areas:

Wilson's disease (wd) drugs market sizing
Wilson's disease (wd) drugs market forecast
Wilson's disease (wd) drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading wilson's disease (wd) drugs market vendors that include ANI Pharmaceuticals Inc., Apotex Inc., AstraZeneca Plc, Bausch Health Companies Inc., Breckenridge Pharmaceutical Inc., Dr Reddys Laboratories Ltd., Endo International Plc, Lupin Ltd., Merck and Co. Inc., Navinta LLC, Noblepharma Co. Ltd., Panacea Biotec Ltd., Recordati S.p.A, Sanofi SA, Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., and Tsumura and Co.. Also, the wilson's disease (wd) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75840

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Wilson'S Disease (WD) Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Wilson'S Disease (WD) Drugs Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
6.3 Retail pharmacies - Market size and forecast 2023-2028
- Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Hospital pharmacies - Market size and forecast 2023-2028
- Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacies - Market size and forecast 2023-2028
- Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
7.3 Chelators - Market size and forecast 2023-2028
- Chart on Chelators - Market size and forecast 2023-2028 ($ million)
- Data Table on Chelators - Market size and forecast 2023-2028 ($ million)
- Chart on Chelators - Year-over-year growth 2023-2028 (%)
- Data Table on Chelators - Year-over-year growth 2023-2028 (%)
7.4 Minerals - Market size and forecast 2023-2028
- Chart on Minerals - Market size and forecast 2023-2028 ($ million)
- Data Table on Minerals - Market size and forecast 2023-2028 ($ million)
- Chart on Minerals - Year-over-year growth 2023-2028 (%)
- Data Table on Minerals - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 ANI Pharmaceuticals Inc.
- ANI Pharmaceuticals Inc. - Overview
- ANI Pharmaceuticals Inc. - Product / Service
- ANI Pharmaceuticals Inc. - Key offerings
12.4 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
12.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
12.6 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
12.7 Breckenridge Pharmaceutical Inc.
- Breckenridge Pharmaceutical Inc. - Overview
- Breckenridge Pharmaceutical Inc. - Product / Service
- Breckenridge Pharmaceutical Inc. - Key offerings
12.8 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
12.9 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
12.10 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Product / Service
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
12.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
12.12 Navinta LLC
- Navinta LLC - Overview
- Navinta LLC - Product / Service
- Navinta LLC - Key offerings
12.13 Panacea Biotec Ltd.
- Panacea Biotec Ltd. - Overview
- Panacea Biotec Ltd. - Product / Service
- Panacea Biotec Ltd. - Key news
- Panacea Biotec Ltd. - Key offerings
12.14 Recordati S.p.A
- Recordati S.p.A - Overview
- Recordati S.p.A - Business segments
- Recordati S.p.A - Key offerings
- Recordati S.p.A - Segment focus
12.15 Taj Pharmaceutical Ltd.
- Taj Pharmaceutical Ltd. - Overview
- Taj Pharmaceutical Ltd. - Product / Service
- Taj Pharmaceutical Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Tsumura and Co.
- Tsumura and Co. - Overview
- Tsumura and Co. - Product / Service
- Tsumura and Co. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR75840

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Wilson'S Disease (WD) Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Distribution Channel
Exhibits35: Data Table on Comparison by Distribution Channel
Exhibits36: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Distribution Channel ($ million)
Exhibits49: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits50: Chart on Product - Market share 2023-2028 (%)
Exhibits51: Data Table on Product - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Product
Exhibits53: Data Table on Comparison by Product
Exhibits54: Chart on Chelators - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Chelators - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Chelators - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Chelators - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Minerals - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Minerals - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Minerals - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Minerals - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Product ($ million)
Exhibits63: Data Table on Market opportunity by Product ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: ANI Pharmaceuticals Inc. - Overview
Exhibits114: ANI Pharmaceuticals Inc. - Product / Service
Exhibits115: ANI Pharmaceuticals Inc. - Key offerings
Exhibits116: Apotex Inc. - Overview
Exhibits117: Apotex Inc. - Product / Service
Exhibits118: Apotex Inc. - Key news
Exhibits119: Apotex Inc. - Key offerings
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bausch Health Companies Inc. - Overview
Exhibits125: Bausch Health Companies Inc. - Business segments
Exhibits126: Bausch Health Companies Inc. - Key news
Exhibits127: Bausch Health Companies Inc. - Key offerings
Exhibits128: Bausch Health Companies Inc. - Segment focus
Exhibits129: Breckenridge Pharmaceutical Inc. - Overview
Exhibits130: Breckenridge Pharmaceutical Inc. - Product / Service
Exhibits131: Breckenridge Pharmaceutical Inc. - Key offerings
Exhibits132: Dr Reddys Laboratories Ltd. - Overview
Exhibits133: Dr Reddys Laboratories Ltd. - Business segments
Exhibits134: Dr Reddys Laboratories Ltd. - Key news
Exhibits135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits136: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits137: Endo International Plc - Overview
Exhibits138: Endo International Plc - Business segments
Exhibits139: Endo International Plc - Key news
Exhibits140: Endo International Plc - Key offerings
Exhibits141: Endo International Plc - Segment focus
Exhibits142: Lupin Ltd. - Overview
Exhibits143: Lupin Ltd. - Product / Service
Exhibits144: Lupin Ltd. - Key news
Exhibits145: Lupin Ltd. - Key offerings
Exhibits146: Merck and Co. Inc. - Overview
Exhibits147: Merck and Co. Inc. - Business segments
Exhibits148: Merck and Co. Inc. - Key news
Exhibits149: Merck and Co. Inc. - Key offerings
Exhibits150: Merck and Co. Inc. - Segment focus
Exhibits151: Navinta LLC - Overview
Exhibits152: Navinta LLC - Product / Service
Exhibits153: Navinta LLC - Key offerings
Exhibits154: Panacea Biotec Ltd. - Overview
Exhibits155: Panacea Biotec Ltd. - Product / Service
Exhibits156: Panacea Biotec Ltd. - Key news
Exhibits157: Panacea Biotec Ltd. - Key offerings
Exhibits158: Recordati S.p.A - Overview
Exhibits159: Recordati S.p.A - Business segments
Exhibits160: Recordati S.p.A - Key offerings
Exhibits161: Recordati S.p.A - Segment focus
Exhibits162: Taj Pharmaceutical Ltd. - Overview
Exhibits163: Taj Pharmaceutical Ltd. - Product / Service
Exhibits164: Taj Pharmaceutical Ltd. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits166: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits168: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits169: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits170: Tsumura and Co. - Overview
Exhibits171: Tsumura and Co. - Product / Service
Exhibits172: Tsumura and Co. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Information sources
Exhibits178: Data validation
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Data synthesis
Exhibits181: 360 degree market analysis
Exhibits182: List of abbreviations